References analysis of the Wikipedia article "Sulfat de condroïtina" in the Catalan version

bmj.com

Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S «Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis». British Medical Journal, 341, 2010, pàg. c4675. DOI: 10.1136/bmj.c4675. PMC: 2941572. PMID: 20847017. Free PDF online

doi.org

dx.doi.org

PA Levene, FB La Forge «On Chondroitin Sulphuric Acid». J. Biol. Chem., 15, 1, 1913, pàg. 69–79. DOI: 10.1016/S0021-9258(18)88542-8.

Barnhill JG, Fye CL, Williams DW, Reda DJ, Harris CL, Clegg DO «Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial». J Am Pharm Assoc [Washington DC], 46, 1, 2006, pàg. 14–24. DOI: 10.1331/154434506775268616.

Silbert, JE; Sugumaran, G «Biosynthesis of chondroitin/dermatan sulfate». IUBMB Life, 54, 4, 2002, pàg. 177-86. DOI: 10.1080/15216540214923. PMID: 12512856 [Consulta: 26 setembre 2024].

Forsyth R, Brigden C, Northrop A «Double blind investigation of the effects of oral supplementation of combined glucosamine hydrochloride (GHCL) and chondroitin sulfate (CS) on stride characteristics of veteran horses». Equine Vet J Suppl, 36, 2006, pàg. 622-5. DOI: 10.1111/j.2042-3306.2006.tb05615.x.

Andermann G, Dietz M «The influence of the route of administration on the bioavailability of an endogenous macromolecule: chondroitin sulfate (CSA)». Eur J Drug Metab Pharmacokinet, 7, 1, 1982, pàg. 11–6. DOI: 10.1007/BF03189537. PMID: 6802643.

Ronca F, Palmieri L, Panicucci P, Ronca G «Anti-inflammatory activity of chondroitin sulfate». Osteoarthritis Cartilage, 6 Suppl A, 1998, pàg. 14-21. DOI: 10.1016/s1063-4584(98)80006-x. PMID: 9743814 [Consulta: 26 setembre 2024].

Monfort J, Pelletier J-P, Garcia-Giralt N, Martel-Pelletier J «Biochemical basis of the effect of chondroitin sulfate on osteoarthritis articular tissues». Ann Rheum Dis, 67, 6, 2008, pàg. 735-40. DOI: 10.1136/ard.2006.068882. PMID: 17644553.

Jomphe C, Gabriac M, Hale TM, Heroux L, Trudeau LE, Deblois D, Montell E, Verges J, du Souich P «Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes». Basic Clin Pharmacol Toxicol, 102, 1, 2008, pàg. 59-65. DOI: 10.1111/j.1742-7843.2007.00158.x. PMID: 17983423 [Consulta: 26 setembre 2024].

Kwan Tat S, Pelletier JP, Verges J, Lajeunesse D, Montell E, Fahmi H, Lavigne M, Martel-Pelletier J «Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study». Arthritis Res Ther, 9, 6, 2007, pàg. R117. DOI: 10.1186/ar2325. PMID: 17996099 [Consulta: 26 setembre 2024].

AD Sawitzke; H Shi; MF Finco; DD Dunlop; CL Harris; NG Singer; JD Bradley; D Silver; CG Jackson; NE Lane; CV Oddis; F Wolfe; J Lisse; DE Furst; CO Bingham; DJ Reda; RW Moskowitz; HJ Williams; DO Clegg «Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT». Annals of the Rheumatic Diseases, 69, 8, 2010, pàg. 1459–64. DOI: 10.1136/ard.2009.120469. PMID: 20525840 [Consulta: 26 setembre 2024].

Bourgeois F, Chales C, Delais J, Delcambre B, Kuntz JL, Rozenber S «Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo». Osteoarthritis Cartilage, 6 Suppl A, 1998, pàg. 25-30. DOI: 10.1016/s1063-4584(98)80008-3. PMID: 9743816 [Consulta: 26 setembre 2024].

Bucsi, L; Poor, G «Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis». Osteoarthritis Cartilage, 6 Suppl A, 1998, pàg. 31-6. DOI: 10.1016/s1063-4584(98)80009-5. PMID: 9743817 [Consulta: 26 setembre 2024].

Uebelhart D, Thonar EJMA, Delmas PD, Chantraine A, Vignon E «Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study». Osteoarthritis Cartilage, 6 Suppl A, 1998, pàg. 39-46. DOI: 10.1016/s1063-4584(98)80011-3. PMID: 9743819 [Consulta: 26 setembre 2024].

D Uebelhart, M Malaise, R Marcolongo, F DeVathaire, M Piperno, E Mailleux, A Fioravanti, L Matoso, E Vignon «Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo». Osteoarthritis and Cartilage, 12, 4, 2004, pàg. 269-276. DOI: 10.1016/j.joca.2004.01.004 [Consulta: 26 setembre 2024].

Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ «Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis». N Engl J Med, 354, 8, 2006, pàg. 795-808. DOI: 10.1056/NEJMoa052771. PMID: 16495392 [Consulta: 26 setembre 2024].

G Verbruggen, S Goemaere, EM Veys «Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA». Osteoarthritis Cartilage, 6 Suppl A, 1998, pàg. 37-8. DOI: 10.1016/s1063-4584(98)80010-1. PMID: 9743818 [Consulta: 26 setembre 2024].

G Verbruggen, S Goemaere, EM Veys «Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs». Clin Rheumatol, 21, 3, 2002, pàg. 231-43. DOI: 10.1007/s10067-002-8290-7. PMID: 12111630.

McAlindon TE, LaValley MP, Gulin JP, Felson DT «Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis». JAMA, 283, 11, 2000, pàg. 1469–1475. DOI: 10.1001/jama.283.11.1469. PMID: 10732937.

F Richy, O Bruyere, O Ethgen, M Cucherat, Y Henrotin, JY Reginster «Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis». Arch Intern Med, 163, 13, 2003, pàg. 1514-22. DOI: 10.1001/archinte.163.13.1514. PMID: 12860572.

S Reichenbach, R Sterchi, M Scherer, S Trelle, E Bürgi, U Bürgi, PA Dieppe, P Jüni «Meta-analysis: chondroitin for osteoarthritis of the knee or hip». Ann Intern Med, 146, 8, 2007, pàg. 580-90. DOI: 10.7326/0003-4819-146-8-200704170-00009. PMID: 17438317.

Bruyere, O; Reginster, JY «Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis». Drugs Aging, 24, 7, 2007, pàg. 573-580. DOI: 10.2165/00002512-200724070-00005. PMID: 17658908.

W Zhang, RW Moskowitz, G Nuki, S Abramson, RD Altman, N Arden, S Bierma-Zeinstra, KD Brandt, P Croft, M Doherty, M Dougados, M Hochberg, DJ Hunter, K Kwoh, LS Lohmander, P Tugwell «OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence». Osteoarthritis Cartilage, 15, 9, 2007, pàg. 981-1000. DOI: 10.1016/j.joca.2007.06.014. PMID: 17719803 [Consulta: 27 setembre 2024].

M Guerrini, D Beccati, Z Shriver, A Naggi, K Viswanathan, A Bisio, I Capila, C Lansing et al. «Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events». Nat Biotechnol, 26, 6, 2008, pàg. 669-75. DOI: 10.1038/nbt1407. PMID: 18437154 [Consulta: 27 setembre 2024].

K Kishimoto, K Viswanathan, T Ganguly, S Elankumaran, S Smith, K Pelzer, C Lansing, N Sriranganathan, et al. «Contaminated heparin associated with adverse clinical events and activation of the contact system». N Engl J Med., 358, 23, 2008, pàg. 2457-67. DOI: 10.1056/NEJMoa0803200. PMID: 18434646 [Consulta: 27 setembre 2024].

R Sasisekharan, Z Shriver «From crisis to opportunity: a perspective on the heparin crisis». Thromb Haemost., 102, 5, 2009, pàg. 854-8. DOI: 10.1160/TH09-02-0083. PMID: 19888519.

nejm.org

nih.gov

ncbi.nlm.nih.gov

Silbert, JE; Sugumaran, G «Biosynthesis of chondroitin/dermatan sulfate». IUBMB Life, 54, 4, 2002, pàg. 177-86. DOI: 10.1080/15216540214923. PMID: 12512856 [Consulta: 26 setembre 2024].

Conte A, Palmieri L, Segnini D, Ronca G «Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat». Drugs Exp Clin Res, 17, 1, 1991, pàg. 27-33. PMID: 1914833.

Conte A, de Bernardi M, Palmieri L, Lualdi P, Mautone G, Ronca G «Metabolic fate of exogenous chondroitin sulfate in man». Arzneimittelforschung, 41, 7, 1991, pàg. 768-72. PMID: 1772467.

Conte A, Volpi N, Palmieri L, Bahous I, Ronca G «Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate». Arzneimittelforschung, 45, 8, 1995, pàg. 918-25. PMID: 7575762.

Palmieri L, Conte A, Giovannini L, Lualdi P, Ronca G «Metabolic fate of exogenous chondroitin sulfate in the experimental animal». Arzneimittelforschung, 40, 3, 1990, pàg. 319-23. PMID: 2112001.

Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L «Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis». J Rheumatol, 23, 8, 1996, pàg. 1385-91. PMID: 8856618.

BF Leeb, H Schweitzer, K Montag, JS Smolen «A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis». J Rheumatol., 27, 1, 2000, pàg. 205-11. PMID: 10648040.

B Mazieres, B Combe, A Phan Van, J Tondut, M Grynfeltt «Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study». J Rheumatol, 28, 1, 2001, pàg. 173-81. PMID: 11196521.

R Sasisekharan, Z Shriver «From crisis to opportunity: a perspective on the heparin crisis». Thromb Haemost., 102, 5, 2009, pàg. 854-8. DOI: 10.1160/TH09-02-0083. PMID: 19888519.

pubmed.ncbi.nlm.nih.gov

meshb.nlm.nih.gov

«Chondroitin Sulfates». MeSH Descriptor Data 2024. National Library of Medicine: Medical Subject Headings (MeSH). [Consulta: 26 setembre 2024].

Sulfat de condroïtina (Catalan Wikipedia)

biomedcentral.com

arthritis-research.biomedcentral.com

bmj.com

doi.org

dx.doi.org

fda.gov

nejm.org

nih.gov

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

meshb.nlm.nih.gov

oarsijournal.com

raco.cat

sciencedirect.com

uab.cat

ddd.uab.cat

web.archive.org

wiley.com

iubmb.onlinelibrary.wiley.com

onlinelibrary.wiley.com